GlassScriptPhysician profile
Stuart A Yablon
NPI 1265477459
$4,069.61
in general payments reported to CMS, 2019-2025
7 companies · $51.02 in 2025
The $51.02 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.00 · 2020: $3,554 · 2021: $54.04 · 2022: $12.17 · 2023: $184 · 2024: $168 · 2025: $51.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $3,500.00 | 2020 | |
| Abbvie INC. | $183.53 | 2023 | Botox |
| Medtronic, INC. | $142.91 | 2021-2025 | Synchromedii |
| Allergan, INC. | $133.61 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $56.26 | 2024 | Xeomin |
| Tersera Therapeutics LLC | $32.48 | 2024 | Prialt |
| Saol Therapeutics INC. | $20.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Yablon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.